IRIS PubliCatt

PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).

PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.

Objective: To compare the diagnostic value of striatal 123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (123I-FP-CIT) single photon emission computed tomography (SPECT) and 123I-metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy in differentiating dementia with Lewy bodies (DLB) from other dementia types. Methods: This prospective longitudinal study included 30 patients with a clinical diagnosis of DLB and 29 patients with non-DLB dementia (Alzheimer disease, n = 16; behavioral variant frontotemporal dementia, n = 13). All patients underwent 123I-FP-CIT SPECT and 123I-MIBG myocardial scintigraphy within a few weeks of clinical diagnosis. All diagnoses at each center were agreed upon by the local clinician and an independent expert, both unaware of imaging data, and re-evaluated after 12 months. Each image was visually classified as either normal or abnormal by 3 independent nuclear physicians blinded to patients' clinical data. Results: Overall, sensitivity and specificity to DLB were respectively 93% and 100% for 123I-MIBG myocardial scintigraphy, and 90% and 76% for 123I-FP-CIT SPECT. Lower specificity of striatal compared to myocardial imaging was due to decreased 123I-FP-CIT uptake in 7 non-DLB subjects (3 with concomitant parkinsonism) who had normal 123I-MIBG myocardial uptake. Notably, in our non-DLB group, myocardial imaging gave no false-positive readings even in those subjects (n = 7) with concurrent medical illnesses (diabetes and/or heart disease) supposed to potentially interfere with 123I-MIBG uptake. Interpretation: 123I-FP-CIT SPECT and 123I-MIBG myocardial scintigraphy have similar sensitivity for detecting DLB, but the latter appears to be more specific for excluding non-DLB dementias, especially when parkinsonism is the only “core feature” exhibited by the patient. Our data also indicate that the potential confounding effects of diabetes and heart disease on 123I-MIBG myocardial scintigraphy results might have been overestimated. Ann Neurol 2016;80:368–378.

Tiraboschi, P., Corso, A., Guerra, U. P., Nobili, F., Piccardo, A., Calcagni, M. L., Volterrani, D., Cecchin, D., Tettamanti, M., Antelmi, L., Vidale, S., Sacco, L., Merello, M., Stefanini, S., Micheli, A., Vai, P., Capitanio, S., Gabanelli, S. V., Riva, R., Pinto, P., Biffi, A. M., Muscio, C., 123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study, <<ANNALS OF NEUROLOGY>>, 2016; 80 (3): 368-378. [doi:10.1002/ana.24717] [http://hdl.handle.net/10807/94047]

• Scheda breve
• Scheda completa

Autori:	Tiraboschi, Pietro Corso, Angelo Guerra, Ugo Paolo Nobili, Flavio Piccardo, Arnoldo Calcagni, Maria Lucia   Volterrani, Duccio Cecchin, Diego Tettamanti, Mauro Antelmi, Luigi Vidale, Simone Sacco, Leonardo Merello, Maria Stefanini, Stefano Micheli, Anna Vai, Paola Capitanio, Selene Gabanelli, Sara Vincenzina Riva, Riccardo Pinto, Patrizia Biffi, Ave Maria Muscio, Cristina Mostra autori esterni Nascondi autori esterni
Titolo:	123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study
Digital Object Identifier (DOI):	http://dx.doi.org/10.1002/ana.24717
URL:	http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1531-8249
Data di pubblicazione:	2016
Abstract:	Objective: To compare the diagnostic value of striatal 123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (123I-FP-CIT) single photon emission computed tomography (SPECT) and 123I-metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy in differentiating dementia with Lewy bodies (DLB) from other dementia types. Methods: This prospective longitudinal study included 30 patients with a clinical diagnosis of DLB and 29 patients with non-DLB dementia (Alzheimer disease, n = 16; behavioral variant frontotemporal dementia, n = 13). All patients underwent 123I-FP-CIT SPECT and 123I-MIBG myocardial scintigraphy within a few weeks of clinical diagnosis. All diagnoses at each center were agreed upon by the local clinician and an independent expert, both unaware of imaging data, and re-evaluated after 12 months. Each image was visually classified as either normal or abnormal by 3 independent nuclear physicians blinded to patients' clinical data. Results: Overall, sensitivity and specificity to DLB were respectively 93% and 100% for 123I-MIBG myocardial scintigraphy, and 90% and 76% for 123I-FP-CIT SPECT. Lower specificity of striatal compared to myocardial imaging was due to decreased 123I-FP-CIT uptake in 7 non-DLB subjects (3 with concomitant parkinsonism) who had normal 123I-MIBG myocardial uptake. Notably, in our non-DLB group, myocardial imaging gave no false-positive readings even in those subjects (n = 7) with concurrent medical illnesses (diabetes and/or heart disease) supposed to potentially interfere with 123I-MIBG uptake. Interpretation: 123I-FP-CIT SPECT and 123I-MIBG myocardial scintigraphy have similar sensitivity for detecting DLB, but the latter appears to be more specific for excluding non-DLB dementias, especially when parkinsonism is the only “core feature” exhibited by the patient. Our data also indicate that the potential confounding effects of diabetes and heart disease on 123I-MIBG myocardial scintigraphy results might have been overestimated. Ann Neurol 2016;80:368–378.
Lingua:	Inglese
Rivista:	ANNALS OF NEUROLOGY
Citazione:	Tiraboschi, P., Corso, A., Guerra, U. P., Nobili, F., Piccardo, A., Calcagni, M. L., Volterrani, D., Cecchin, D., Tettamanti, M., Antelmi, L., Vidale, S., Sacco, L., Merello, M., Stefanini, S., Micheli, A., Vai, P., Capitanio, S., Gabanelli, S. V., Riva, R., Pinto, P., Biffi, A. M., Muscio, C., 123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study, <<ANNALS OF NEUROLOGY>>, 2016; 80 (3): 368-378. [doi:10.1002/ana.24717] [http://hdl.handle.net/10807/94047]
Appare nelle tipologie:	Articolo in rivista, Nota a sentenza

File in questo prodotto:

File	Descrizione	Tipologia	Note	Licenza
TIRABOSCHI_2016.pdf		Versione Editoriale (PDF)	Nessuna Nota		Open Access Visualizza/Apri

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/10807/94047

• Citazioni
• 
• 
• 

Powered by IRIS-about IRIS-Utilizzo dei cookie

 Copyright © 2021